Results
1 -
3 of
3
(Click
here to explore results)
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 4 Natural Compounds and Synthetic Drugs to Target Type-2 Cannabinoid (CB2) Receptor. Wolfgang Guba, Marc Nazaré, Uwe Grether
, 2021
, Pages 89-167
- Anti-Inflammatory Drug Discovery, CHAPTER 13 Recent Advances in Selective CB2 Agonists for the Treatment of Pain. E. J. GILBERT, C. A. LUNN
, 2012
, Pages 391-413
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 5 Natural and Synthetic Cannabinoids Targeting Non-CB1, Non-CB2 G Protein-coupled Receptors. Paula Morales, Israa H. Isawi, Patricia H. Reggio
, 2021
, Pages 168-200